Abstract

BackgroundThe chronic inflammation in patients with rheumatoid arthritis (RA) increases the risk for cardiovascular diseases (CVD). The contribution of diet as a risk factor for CVD among these patients is however not fully understood. The aim of this study is to investigate if a proposed anti-inflammatory diet improves cardiovascular profile in weight stable patients with RA.MethodsPatients (n = 50) with RA were included in a cross-over trial. They were randomized to either a diet rich in whole grain, fatty fish, nuts, vegetables and fruit and supplemented with probiotics, or a control diet resembling average nutritional intake in Sweden, for ten weeks. After a 4-month washout they switched diet. Participants received food bags and dietary guidelines. Primary outcome was triglyceride (TG) concentration. Secondary outcomes were total-, high density lipoprotein- (HDL) and low density lipoprotein- (LDL) cholesterol, Apolipoprotein-B100 and -A1, lipoprotein composition, plasma phospholipid fatty acids and blood pressure.ResultsForty-seven patients completed at least one period and they remained weight stable. There was a significant between-dietary treatment effect in TG and HDL-cholesterol concentration in favor of intervention (p = 0.007 and p = 0.049, respectively). Likewise, Apolipoprotein-B100/A1 ratio shifted toward a less atherogenic profile in favor of the intervention (p = 0.007). Plasma fatty acids increased in polyunsaturated- and decreased in monounsaturated- and saturated fatty acids between diet periods in favor of the intervention period.ConclusionBlood lipid profile improved indicating cardioprotective effects from an anti-inflammatory dietary intervention in patients with RA.Trial registrationThis trial is registered at ClinicalTrials.gov as NCT02941055.

Highlights

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease that is characterized by systemic inflammation and joint damage

  • Even though pharmacological treatment has improved in recent decades, risk of cardiovascular diseases (CVD) compared to the general population remains elevated [3]

  • Inclusion criteria were active disease defined as DAS28-ESR ≥2.6, stable disease activity defined as no changes in disease-modifying antirheumatic drugs (DMARD) therapy during the past 8 weeks, age 18–75 years, and at least 2 years disease duration

Read more

Summary

Introduction

Rheumatoid arthritis (RA) is a chronic autoimmune disease that is characterized by systemic inflammation and joint damage. Patients with RA have a shorter life expectancy compared to the general population [1], and have a substantially increased risk of cardiovascular diseases (CVD) [2]. Even though pharmacological treatment has improved in recent decades, risk of CVD compared to the general population remains elevated [3]. Primary risk factors for CVD include dyslipidemia, e.g. elevated low density lipoprotein (LDL) cholesterol and triglyceride (TG), low high density lipoprotein (HDL) cholesterol, as well as high Apolipoprotein-B100 (Apo-B100) concentrations [4] .In RA, studies investigating dyslipidemia in relation to CVDevents have not always shown consistent results. The chronic inflammation in patients with rheumatoid arthritis (RA) increases the risk for cardiovascular diseases (CVD).

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call